Heterocyclic Thioacetamide Synthesis
Tech ID
P27-1402
Patent Status
Granted in India
Design Status
--
Technical Description
This technology is a novel class of heterocyclic thioacetamide derivatives designed to effectively inhibit SHP2 for therapeutic applications in SHP2-mediated diseases.
Problems Addressed
- Limited Aquaporin 9 Modulation
- Inefficient Hyperglycemia Control
- Restricted Apoptosis Activation
- Low Membrane Depolarization
- Limited Antimicrobial Activity
- Inefficient SHP2 Inhibition
TARGET AUDIENCE
- Pharmaceutical Industry
- Biotechnology Sector
- Healthcare & Therapeutics Industry
- Academic & Research Institutions
- Life Sciences & Precision Medicine Industry
TECH FEATURES
- Efficient SHP2 Inhibition
- Enhanced Binding Mechanism
- Targeted Enzyme Modulation
- Improved Antioxidant Activity
- Optimized Antiproliferative Effects
P27-1402
Send download link to email.
Available For
Available for exclusive and non exclusive license
Sell off
Cost
—
Stage of Developments
Technology Validated
Contact Person
Mr. Lalit Ambastha
IP Bazzaar Technology Pvt. Ltd.
IP Bazzaar Technology Pvt. Ltd.
12 First Floor, National Park, Lajpat Nagar-IV,
New Delhi-110024, India
Tel: [+91] 11-26360036;
Fax: [+91] 11-26360037;
Mobile: [+91]9811367838;
Email: tech@ipbazzaar.com;
www.ipbazzaar.com
New Delhi-110024, India
Tel: [+91] 11-26360036;
Fax: [+91] 11-26360037;
Mobile: [+91]9811367838;
Email: tech@ipbazzaar.com;
www.ipbazzaar.com